RSV often looks like a cold – but sometimes it's more serious. Here's when to call the doctor and how to help your child feel ...

Cases of the respiratory illness are rising in January 2026 across the state, including in the Sacramento area.

With over 3,200 cases already reported this season and FDA-approved immunizations now available, medical professionals urge ...

Giving the long-acting monoclonal antibody nirsevimab to most infants sharply reduced hospitalizations and clinic visits ...

Nirsevimab is a long-acting monoclonal antibody that provides season-long protection against RSV in infants, reducing medically attended infections and hospitalizations. Maternal vaccination and ...

A second monoclonal antibody to prevent respiratory syncytial virus (RSV) in infants has been recommended by the CDC’s Advisory Committee on Immunization Practices (ACIP). Five members voted yes and ...

Doctors at Intermountain Health are seeing a big difference in infant hospitalizations for RSV after pushing for Utahns to ...

Mississippi has seen more whooping cough cases in 2025 than it has in the previous 16 years. Are flu-like illness rates and ...

This article is part of “Innovations In: RSV,” an editorially independent special report that was produced with financial support from MSD, Sanofi and AstraZeneca. Susan Green developed a stubborn ...